Neal Flomenberg, MD
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University · Thomas Jefferson University
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Neal Flomenberg, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 11:29 UTC. Open this list on ClinicalTrials.gov
- N/ANCT03944265 · Genetics and Shared Decision Making in Improving Care for Patients With Stage IVA-C Non-small Cell Lung CancerThomas Jefferson University · completed · Activating ALK Gene Mutation Negative, Activating EGFR Gene Mutation Negative, Activating ROS1 Gene Mutation Negative · principal investigator
- Ph2NCT01760655 · Reduced-Intensity Conditioning Before Donor Stem Cell Transplant in With High-Risk Hematologic MalignanciesSidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University · completed · Acute Myeloid Leukemia With FLT3/ITD Mutation, Acute Myeloid Leukemia With Gene Mutations, Acute Myeloid Leukemia With Inv(3) (q21.3;q26.2); GATA2, MECOM · principal investigator
- Ph2NCT01532635 · A Two-Step Approach to Bone Marrow Transplant Using Cells From Two Partially-Matched RelativesSidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University · terminated · Hematologic Malignancy, Leukemia, Acute Lymphoblastic Leukemia · principal investigator
- Ph1/Ph2NCT01350258 · Bone Marrow Transplant Using a Reduced Intensity Regimen That is Given in Two StepsSidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University · terminated · Hematologic Malignancies, Acute Leukemia, Myelodysplastic Syndromes (MDS) Other Than RA or RARS Subtypes · principal investigator
- Ph2NCT01350245 · Bone Marrow Transplantation of Patients in Remission Using Partially Matched Relative DonorSidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University · completed · Acute Myeloid Leukemia, Myelodysplastic Syndromes, Biphenotypic Leukemia · principal investigator
- Ph2NCT01341301 · Donor Stem Cell Transplant in Treating Patients With High-Risk Hematologic MalignanciesSidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University · completed · Hematologic Malignancy · principal investigator
- Ph2NCT01315132 · A Study of Bone Marrow Transplantation Using Fully-Matched Relatives as Donors for Patients With Hematological MalignanciesSidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University · completed · Hematological Malignancies, Leukemia, Lymphoma · principal investigator
- Ph1/Ph2NCT01162096 · Reduced Intensity Haploidentical Transplant for Hematological MalignanciesSidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University · completed · Hematological Malignancies · principal investigator
- Ph1/Ph2NCT00429143 · A Two-Step Approach to Bone Marrow Transplant Using Cells From A Partially-Matched RelativeSidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University · completed · Hematologic Malignancies · principal investigator
- Ph2NCT00014508 · Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Multiple MyelomaEastern Cooperative Oncology Group · completed · Multiple Myeloma and Plasma Cell Neoplasm · study chair
- Ph1NCT00003268 · Amifostine and Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Myeloid LeukemiaSidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University · completed · Drug/Agent Toxicity by Tissue/Organ, Leukemia · study chair
- Ph2NCT00003153 · Biological Therapy in Treating Patients With Multiple Myeloma That Has Recurred Following Bone Marrow TransplantationEastern Cooperative Oncology Group · completed · Multiple Myeloma and Plasma Cell Neoplasm · study chair
Grants
NIH projects from RePORTER, fetched 2026-11-12 11:29 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in childhood acute lymphoblastic leukemia.